Episode #93: ArminLabs with Dr. Armin Schwarzbach, MD, PhD

Why You Should Listen:

In this episode, you will learn about EliSpot testing and the various testing options available through ArminLabs in Germany.

About My Guest:

My guest for this episode is Dr. Armin Schwarzbach. Armin Schwarzbach, MD, PhD is a medical doctor and a specialist in laboratory medicine from the laboratory ArminLabs in Augsburg, Germany. Dr. Schwarzbach began by studying biochemistry at Hoechst AG in Frankfurt, Germany and pharmacy at the University of Mainz in Germany in 1984. In 1985 he studied medicine for 6 years at the University of Mainz and finished his MD in 1991. Dr. Schwarzbach developed the worldwide first Radioimmunoassay (RIA) for human Gastric Inhibitory Polypeptide from 1986 – 1991, getting his PhD in 1992. He is member of the Swiss Association for tick-borne diseases, the German Association of Clinical Chemistry and Laboratory Medicine, and the German Society for Medical Laboratory Specialists. He is an Advisory Board member of AONM London, England, and Board member of German Borreliosis Society, and Member and former Board Member of the International Lyme and Associated Diseases Society (ILADS) and has served as an expert on advisory committees on Lyme Disease in England, Australia, Canada, Ireland, France, and Germany. Dr. Schwarzbach is the founder and CEO of ArminLabs in Augsburg, Germany and has specialized in diagnostic tests and treatment options for patients with tick-borne diseases for over 20 years.

Key Takeaways:

- What is an EliSpot?
- What organisms can be tested for using EliSpot technology?
- How specific is the EliSpot in testing for Borrelia, Bartonella, Babesia, and other organisms?
- Does the state of the immune system matter when considering EliSpot results?
- Which infections are the most persistent?
- Can the EliSpot be used to track progress or success of treatment?
- What is Yersinia and where might it be encountered?
- Can EliSpot testing be used in newborns and infants?
- What role do viruses such as EBV, CMV, Coxsackie, and others play in chronic illness?
- Can Mast Cell Activation Syndrome be triggered by viruses?
- Why are Mycoplasma and Chlamydia so important to explore?
- Why is IgA testing a promising new direction in laboratory medicine?
- Is CD57 helpful clinically?
- What microbes are more commonly associated with specific medical conditions?
- How common are Rickettsial organisms?
- What is "Post Lyme Syndrome"? Is it real?

Connect With My Guest:

http://arminlabs.com

Interview Date:

February 27, 2019

Additional Information:

To learn more, visit http://BetterHealthGuy.com.

Disclaimer:

The content of this show is for informational purposes only and is not intended to diagnose, treat, or cure any illness or medical condition. Nothing in today's discussion is meant to serve as medical advice or as information to facilitate self-treatment. As always, please discuss any potential health-related decisions with your own personal medical authority.